Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Biomarkers in breast cancer with high over-expression of HER2 protein].

Ginecologia y obstetricia de Mexico - 1 Apr 2001

Cuesta-Mejías T, Mendoza-Ramón H, Alcaraz-Silva J, Evaristo-Torres J, Ortiz-Hidalgo C

Abstract excerpt

INTRODUCTION: The predictive value of the HER2 protein over-expression in order to the breast carcinomas response to dexorubicin and Herceptin therapy has been proved. DAKO Herceptest pretend to be a tool in the identification of patients for whose Herceptin might be an option. In one breast carcinoma serie studied in our laboratory we detected a high over-expression of HER2. Only four cases were recurrent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma
Share to Gene Expression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Phenotype

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 11452415

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Biomarkers in breast cancer with high over-expression of HER2 protein].PMID 11452415Read ↗

Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond.Semantic proximity Read ↗

Unusual Patterns of HER2 Expression in Breast Cancer: Insights and PerspectivesSemantic proximity Read ↗

[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications].Semantic proximity Read ↗

[Immunohistochemical characterisation of breast cancer: towards a new clasification?].Semantic proximity Read ↗

[Diagnosis of HER2 gene amplification in breast carcinoma].Semantic proximity Read ↗

Simultaneous fluorescence immunophenotyping and Her-2/neu genotyping (FICTION) in breast carcinoma candidates to target therapy.Semantic proximity Read ↗

[Current molecular prognostic factors in breast carcinoma].Semantic proximity Read ↗

Factors predictive of response to hormone therapy in breast cancer.Semantic proximity Read ↗

Role of HER2 gene overexpression in breast carcinomaSemantic proximity Read ↗

Role of HER2/neu in tumor progression and therapy.Semantic proximity Read ↗

Immunohistochemical study of p53 and Ki67 in a group of patients with mammary carcinoma.Semantic proximity Read ↗

[Different phenotypes generated by changes in bcl-2 and p53 expression in breast cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.